In this episode, Erin Michos, MD, FACC, and Alison Bailey, MD, FACC discuss the CLEAR Outcomes primary prevention analysis focusing on bempedoic acid and its clinical implications.

This podcast is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant initiative.

Educational grant support is provided by Esperion.

Related References:

1. Nissen SE, Menon V, Nicholls SJ, et al. Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA. 2023;330:131-140.